Baxter Announces U.S. FDA Clearance Of Novum IQ Syringe Infusion Pump With Dose IQ Safety Software
Furthers Baxter's continued innovation in medication delivery and management
Integrates Baxter's decades of leadership in infusion therapy with innovative digital health solutions to build on the company's
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Goldman Sachs Maintains Sell on Baxter Intl, Lowers Price Target to $60
Goldman Sachs analyst Amit Hazan maintains Baxter Intl (NYSE:BAX) with a Sell and lowers the price target from $70 to $60.
Raymond James Maintains Outperform on Baxter Intl, Lowers Price Target to $66
Raymond James analyst Jayson Bedford maintains Baxter Intl (NYSE:BAX) with a Outperform and lowers the price target from $85 to $66.
Morgan Stanley Maintains Overweight on Baxter Intl, Lowers Price Target to $72
Morgan Stanley analyst Drew Ranieri maintains Baxter Intl (NYSE:BAX) with a Overweight and lowers the price target from $86 to $72.
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
Gainers
Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 2022.
Where Baxter Intl Stands With Analysts
Baxter Intl (NYSE:BAX) has observed the following analyst ratings within the last quarter: